Observations: Global Maritime and Air Cargo Logistics

Introduction As of March 2025, the global logistics landscape is experiencing significant shifts, particularly in maritime and air cargo sectors. These changes are influenced by factors such as evolving capacity dynamics, geopolitical developments,…

Global Trade & Logistics Briefing – March 2025

Overview As of March 2025, two major developments—Germany's proposed stimulus and the United States' renewed military efforts in the Red Sea—are expected to significantly impact the global logistics and supply chain landscape. In tandem…

Euro-American’s Expertise in Mitigating Tariff Impacts

In this turbulent trade environment, Euro-American Worldwide Logistics serves as a critical partner for businesses facing the 25% tariffs. With decades of experience in customs brokerage, cross-border freight forwarding, and international trade…

Navigating the New Tariff Regulations: Practical Guidance

Successfully shipping goods under the new tariff regime requires meticulous attention to customs procedures, tariff classification, and regulatory compliance. Both U.S. exporters and Canadian importers should take proactive steps to avoid delays…

Challenges for U.S. Exporters and Canadian Importers

For U.S. Exporters: American businesses exporting to Canada now face a more challenging market. The 25% surtax acts as a price disadvantage – effectively a tax that Canadian buyers must pay, making U.S. products costlier than identical goods…

Navigating Canada’s 25% Tariffs on U.S. Goods: Impacts on Cross-Border Trade, Supply Chains, and Compliance

Introduction On March 4, 2025, Canada implemented a 25% tariff (surtax) on a broad range of imports from the United States, amounting to roughly $30 billion worth of U.S. goods (canada.ca)​. These tariffs were introduced as retaliation for…

Freight Challenges in Life Sciences: 2025 Outlook

Pharmaceutical and life sciences supply chains continue to face turbulence as we head into 2025. Ongoing global disruptions, high transportation costs, and capacity constraints are challenging the delivery of medicines and research materials…

Emerging Regulatory Challenges in Pharmaceutical Logistics

Pharmaceutical logistics is a highly regulated field, and recent years have brought a fast-evolving regulatory environment that logistics professionals must navigate​ (globaltrademag.com). Compliance requirements are becoming more stringent…

The Role of 3PLs in Global Trade Compliance for Pharma

Navigating international trade regulations is a major challenge for pharmaceutical companies. Importing or exporting medicines involves complying with a web of customs laws, healthcare regulations, and security protocols in each country. This…

Pharmaceutical Serialization and Track-and-Trace: Ensuring Compliance in 2025

In November 2023, the pharmaceutical industry reached a major milestone: the deadline for implementing the Drug Supply Chain Security Act (DSCSA) requirements for unit-level serialization and electronic track-and-trace. As we enter 2025, full…

North American Supply Chains: Key Updates and Emerging Trends

Truck Tonnage Outlook Shows Positive Growth The forecast for U.S. truck tonnage in 2025 indicates a 4.6% growth rate, suggesting a gradual recovery in the first half of the year before accelerating in Q3 and Q4. If trends hold, tonnage could…

How U.S. Import Regulations Are Changing for Pharma and Biotech in 2025

The regulatory landscape for importing pharmaceutical and biotechnology products into the United States is undergoing significant changes. Both the Food and Drug Administration (FDA) and U.S. Customs and Border Protection (CBP) have introduced…

AI and Automation in Pharma Supply Chain Management

In an era where digital transformation is reshaping every industry, pharmaceutical supply chains are embracing Artificial Intelligence (AI) and automation to boost efficiency and reliability. The pharma supply chain is complex, involving sensitive…

Cold Chain Integrity in Pharmaceutical and Biotech Logistics

Maintaining a robust cold chain is critical for pharmaceutical and biotech supply chains. Many drugs, vaccines, and biologics must be kept within strict temperature ranges during storage and transit to preserve their efficacy. In fact, temperature-controlled…

Key Updates in International Supply Chains: 2025 Insights

Global Manufacturing Sees a Positive Start in 2025 Recent global manufacturing data indicates a modest rebound, aligning with industry expectations. Eighteen out of thirty countries reported expanding Purchasing Managers’ Index (PMI) readings,…

Nearshoring in Pharma Supply Chains: Can the U.S. Reduce Dependence on Overseas Manufacturing?

The COVID-19 pandemic and global disruptions have exposed the vulnerabilities of pharmaceutical supply chains that rely heavily on overseas manufacturing. In response, many in the industry and government are exploring nearshoring – shifting…

How Biotech Startups Can Scale Logistics Efficiently

Biotech startups are often laser-focused on scientific innovation – developing a novel therapy or diagnostic that could change lives. However, as these startups progress from R&D to clinical trials and ultimately to commercialization,…

Best Practices for cGMP-Compliant Storage and Temperature-Sensitive Shipping

In the pharmaceutical and biotech industries, maintaining product quality isn’t just about how drugs are manufactured – it’s equally about how they are stored and shipped. Many of today’s medicines, especially biologics, vaccines, and…

New U.S. Steel and Aluminum Tariffs Shake Global Trade: What Businesses Need to Know

Introduction The global trade landscape shifted dramatically on March 12, 2025, when the United States reinstated a 25% tariff on all imported steel and aluminum, extending duties to hundreds of downstream products. The move, aimed at strengthening…

The Future of Biologic Drug Cold Chain Management

Biologic medicines – from vaccines and insulin to advanced cell and gene therapies – are often temperature-sensitive and require strict cold chain management. In recent years, the rise of biologics has brought new challenges in storing and…

Third-Party Satellite Facilities – Mitigating CDMO Risks

Introduction In the fast-evolving landscape of pharmaceutical manufacturing, Contract Development and Manufacturing Organizations (CDMOs) have become essential partners for drug companies, providing outsourced services from drug development…

Expanding Horizons: Big Pharma’s Strategic Shift to Emerging Markets

Introduction As the pharmaceutical landscape faces slowing growth in traditional strongholds, major pharmaceutical companies are turning their focus towards emerging markets. Countries like India, China, and Brazil are witnessing significant…

The Rising Role of CDMOs in Pharmaceutical Manufacturing in the USA: Addressing the Need for Third-Party Satellite Facilities to Support Materials Management

Executive Summary In recent years, the Contract Development and Manufacturing Organization (CDMO) industry has experienced substantial growth, particularly in the United States, driven by the increasing complexity of drug development and the…

The Strategic Need for Third-Party Satellite Facilities in U.S. CDMO Operations

Introduction The Contract Development and Manufacturing Organization (CDMO) sector has become a critical player in the U.S. pharmaceutical industry, particularly as companies increasingly outsource drug development and manufacturing to focus…